STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis
- PMID: 19644887
- DOI: 10.1002/art.24688
STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis
Abstract
Objective: Systemic sclerosis (SSc) belongs to the group of connective tissue disorders (CTDs), among which are several disorders characterized by a type I interferon (IFN) signature. The recent identification of an association between IRF5 and SSc further highlights a key role for IFN. STAT4, which encodes STAT-4, contributes to IFN signaling, and its genetic variants were found to be associated with CTDs. The aim of this study was to determine whether the STAT4 rs7574865 single-nucleotide polymorphism is associated with SSc, and whether it interacts with IRF5.
Methods: Both the STAT4 rs7574865 and IRF5 rs2004640 polymorphisms were genotyped in 1,855 individuals of French Caucasian origin comprising a discovery set of 440 patients with SSc and 485 control subjects and a replication set of 445 patients with SSc and an additional 485 control subjects.
Results: STAT4 rs7574865 was shown to be associated with SSc (P=0.001, odds ratio [OR] 1.29, 95% confidence interval [95% CI] 1.11-1.51). This association was not restricted to a particular phenotype. An additive effect of the STAT4 rs7574865 T allele and the IRF5 rs2004640 T allele was observed, resulting in a multiple increased 1.28-fold risk of SSc. The OR for SSc was 2.72 (95% CI 1.86-3.99) for combinations of genotypes with >or=3 risk alleles. An additive effect was also detected for fibrosing alveolitis: carriage of at least 3 risk alleles appeared to be an independent risk factor (P=2.2x10(-4), OR 1.97, 95% CI 1.28-3.04).
Conclusion: Our results establish STAT4 rs7574865 as a new SSc genetic susceptibility factor. STAT4 and IRF5 act with additive effects in terms of susceptibility to both SSc and SSc-related fibrosing alveolitis.
Similar articles
-
The status of pulmonary fibrosis in systemic sclerosis is associated with IRF5, STAT4, IRAK1, and CTGF polymorphisms.Rheumatol Int. 2017 Aug;37(8):1303-1310. doi: 10.1007/s00296-017-3722-5. Epub 2017 Apr 22. Rheumatol Int. 2017. PMID: 28434122 Review.
-
Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity.J Rheumatol. 2010 May;37(5):987-92. doi: 10.3899/jrheum.091163. Epub 2010 Mar 15. J Rheumatol. 2010. PMID: 20231204
-
Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population.Arthritis Rheum. 2009 Jun;60(6):1845-50. doi: 10.1002/art.24600. Arthritis Rheum. 2009. PMID: 19479858
-
Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease.Clin Rheumatol. 2020 Apr;39(4):1173-1179. doi: 10.1007/s10067-019-04922-6. Epub 2020 Jan 8. Clin Rheumatol. 2020. PMID: 31916109 Free PMC article.
-
Polymorphisms in STAT4 and IRF5 increase the risk of systemic sclerosis: a meta-analysis.Int J Dermatol. 2016 Apr;55(4):408-16. doi: 10.1111/ijd.12839. Epub 2015 Dec 29. Int J Dermatol. 2016. PMID: 26712637 Review.
Cited by
-
KCNA5 gene is not confirmed as a systemic sclerosis-related pulmonary arterial hypertension genetic susceptibility factor.Arthritis Res Ther. 2012 Dec 27;14(6):R273. doi: 10.1186/ar4124. Arthritis Res Ther. 2012. PMID: 23270786 Free PMC article.
-
Pathogenesis of pulmonary fibrosis in systemic sclerosis: lessons from interstitial lung disease.Curr Rheumatol Rep. 2010 Feb;12(1):19-25. doi: 10.1007/s11926-009-0071-8. Curr Rheumatol Rep. 2010. PMID: 20425529 Review.
-
The role of type 1 interferon in systemic sclerosis.Front Immunol. 2013 Sep 6;4:266. doi: 10.3389/fimmu.2013.00266. Front Immunol. 2013. PMID: 24046769 Free PMC article. Review.
-
The status of pulmonary fibrosis in systemic sclerosis is associated with IRF5, STAT4, IRAK1, and CTGF polymorphisms.Rheumatol Int. 2017 Aug;37(8):1303-1310. doi: 10.1007/s00296-017-3722-5. Epub 2017 Apr 22. Rheumatol Int. 2017. PMID: 28434122 Review.
-
The pulmonary fibrosis-associated MUC5B promoter polymorphism does not influence the development of interstitial pneumonia in systemic sclerosis.Chest. 2012 Dec;142(6):1584-1588. doi: 10.1378/chest.12-0110. Chest. 2012. PMID: 22576636 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous